Document is current
Any future updates will be listed below
-
Authors
Adeleke, Sola
Galante, Joao R.
Wang, Yishen
Azad, Gurdip https://orcid.org/0000-0002-5373-1777
Wan, Simon
Haroon, Athar
Bianchini, Diletta
Bomanji, Jamshed
Hofman, Michael S. https://orcid.org/0000-0001-8622-159X
Young, Travis S.
Cook, Gary J. R. https://orcid.org/0000-0002-8732-8134
- License Information
-
More Information
Article History
Accepted: 13 October 2025
First Online: 10 November 2025
Competing interests
: M.S.H. acknowledges philanthropic/government grant support from the Prostate Cancer Foundation (PCF), including CANICA Oslo Norway, Peter MacCallum Foundation and NHMRC Investigator Grant; other funding in the past 10 years from Movember/Medical Research Future Fund (MRFF), US Department of Defense and the Prostate Cancer Foundation of Australia (PCFA); research grant support (to Peter MacCallum Cancer Centre) from Novartis, ANSTO, Bayer, Isotopia and MIM; and consulting fees for lectures or advisory boards from Janssen and MSD in the past 2 years and AstraZeneca, Astellas and Mundipharma in the past 5 years. T.S.Y. receives research funding support from AbbVie. G.J.R.C. receives research support from Theragnostics, NanoMab Technology (UK) and Siemens Healthineers; provides consultancy and advisory board support to Serac Healthcare, Amgen, Telix Pharmaceuticals, Blue Earth Diagnostics, NanoMab Technology (UK), GE Healthcare and Full Life Technology; and receives lecture fees from Telix Pharmaceuticals and Curium. The other authors declare no competing interests.
